MITOSAN PLUS 80mg+12.5mg Tablet contains Mitotane 80 mg and Hydrocortisone 12.5 mg. It is a combination medicine used mainly in the management of adrenocortical carcinoma (ACC). Mitotane reduces adrenal cortical tumor activity, while hydrocortisone provides corticosteroid replacement when adrenal hormone production is reduced.
Uses:
Treatment of adrenocortical carcinoma (cancer of the adrenal cortex).
Helps control excessive adrenal hormone production associated with adrenal tumors.
Provides cortisol replacement support during mitotane therapy.
Used under the supervision of an oncologist or endocrinologist.
Dose:
Adults: Dose is individualized according to disease severity, body weight, mitotane blood levels, adrenal hormone levels, and response to treatment.
Take the medicine exactly as prescribed by a healthcare professional.
Dose and duration depend on the patient's condition and monitoring results.
Regular monitoring of mitotane levels, adrenal hormones, liver function, and clinical condition is required.
Do not stop or change the dose without medical advice.